Health News

Obesity is a True Friend of Breast Cancer
Obesity is a risk factor for many diseases. This is especially true in the case of breast cancer. Researchers are showing that obesity complicates the course of disease.
Boosting Bone Density and Extending Lives
Postmenopausal breast cancer patients are often prescribed aromatase inhibitors after primary treatment to reduce the risks of disease recurrence. These drugs can cause bone density loss, though.
The Biology and Socioeconomics of Breast Cancer
While white women in the United States are diagnosed more frequently with breast cancer, women of color are more likely to die of the disease. New research confirms this.
Breast Cancer Therapy May Carry Increased Relapse Risk
Brachytherapy places small radioactive sources into the breast cancer tumor bed to kill off any cells that remain after a lumpectomy. It's faster than standard whole-breast radiation therapy. This method may have some serious drawbacks, though.
How Women can Trim Breast Cancer Risks
You've probably heard that obesity is a risk factor for breast cancer. Now researchers are finding diabetes is another. And there are other things that both increase and decrease a woman's risk of getting breast cancer.
Mammography Saves Lives. Period.
Controversy has swirled around when to start mammography and how often to have these breast cancer screenings. New research says what's important is for women just to have them done.
Diabetes Drug Slows Breast Cancer
What if you could take a drug that costs less than $10 a month to prevent or treat breast cancer? Not a bad deal. Just such a scenario may not be too far off.
You're at High Risk of Breast Cancer
Start mammography at age 40. No, make it 50. Oh hell, if you don't feel like it - don't have a mammogram at all. So, are you confused? Well don't be.
MammaCare Standardizes a Private Cancer Event
It used to be that breast self-exams were something that your doctor urged you to do every month. But very few women and even many healthcare professionals are not adept at feeling slight changes in breast tissue. A new tool aims to change that.
FDA Revokes Approval of Breast Cancer Drug
FDA Commissioner Margaret A. Hamburg, MD, said she is revoking the agency’s approval of the breast cancer indication for Avastin ( bevacizumab ) after concluding that the drug has not been shown to be safe and effective for that use.